Home/Peptides/Thymosin Alpha-1
IMMUNE PEPTIDE

Thymosin Alpha-1

Thymosin Alpha-1 (Tα1)

Immune-modulating peptide with decades of clinical use in chronic infection and cancer-adjunct settings.

FDA STATUS
FDA orphan-drug / clinical-use status in certain settings
HALF-LIFE
~2 hours
ROUTE
Subcutaneous
CLASSIFICATION
Synthetic 28-amino-acid immune-modulating peptide

Overview

Thymosin Alpha-1 (Tα1) is a synthetic analog of a peptide naturally produced by the thymus gland. It has decades of clinical use, particularly in chronic hepatitis and as a cancer-treatment adjunct — it's approved for specific indications in 35+ countries outside the US. Under the 2026 reclassification, it's now a Category 1 peptide available via 503A compounding pharmacies.

The primary mechanism is T-cell maturation support. Tα1 helps the thymus convert immature lymphocytes into functional T-cells, restoring immune function in contexts where it's depleted (chronic infection, aging, stress, cancer therapy). This makes it one of the most clinically validated peptides in the immune category.

In optimization use, it's typically cycled for immune resilience — post-illness recovery, chronic low-grade infection concerns (EBV, CMV, Lyme), or preventative support in high-stress periods.

Mechanism of Action

Tα1 stimulates the maturation of bone-marrow lymphocytes into functional T-cells, enhances NK cell activity, and modulates cytokine signaling to rebalance Th1/Th2 response. In chronic-infection contexts, it supports the Th1 (cellular) arm that's often depleted.

Community Usage Patterns

1.6 mg SC, 2× per week is the most common protocol. Some immune-focused protocols run 600 mcg daily or 3 mg twice-weekly. Cycles typically 12–24 weeks. Common combos: with peptides for chronic infection workups, or post-illness for recovery support. Effects are often subjective (fewer illnesses, faster recovery) rather than lab-visible, but hs-CRP and NK cell panels can show changes.

Education only — not medical advice. Any protocol change should involve your licensed provider.

Biomarkers to Track

When running Thymosin Alpha-1, these are the biomarkers most commonly tracked to assess response and safety:

CBC with differentialhs-CRPNK cell activity (specialized)Lymphocyte subsets

Reconstitution Calculator

Free calculator for Thymosin Alpha-1 reconstitution math — vial size, BAC water volume, and exact syringe units.

Open Thymosin Alpha-1 calculator →

Related Peptides

BPC-157
Healing
Track Thymosin Alpha-1 against your labs.

Log doses, upload your lab PDFs, and let StackAI read your panel in context of what you're actually running. Free to start.

Start tracking →

This page is informational and does not constitute medical advice. MyProtocolStack is a tracking and education platform. Work with a licensed provider before starting, changing, or stopping any protocol.